eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
3/2021
vol. 17
 
Share:
Share:
more
 
 
abstract:
Original paper

Correlation between electromechanical parameters (NOGA XP) and changes of myocardial ischemia in patients with refractory angina

Radosław Kurzelowski
1
,
Kamil Barański
2
,
Guido Caluori
3, 4
,
Wojciech Szot
5
,
Krzysztof Grabowski
6
,
Aleksandra Michalewska-Włudarczyk
1
,
Marcin Syzdół
1
,
Wacław Kuczmik
7
,
Anna Błach
1
,
Beata Ochała
1
,
Damian Hudziak
8
,
Jacek Wilczek
9
,
Krzysztof S. Gołba
9
,
Zdenek Starek
10, 11
,
Michał Tendera
1
,
Wojciech Wojakowski
1
,
Tomasz Jadczyk
1, 10

1.
Department of Cardiology and Structural Heart Disease, Medical University of Silesia, Katowice, Poland
2.
Department of Epidemiology, Medical University of Silesia, Katowice, Poland
3.
IHU LIRYC, Electrophysiology and Heart Modeling Institute, Fondation Bordeaux Université, Pessac, France
4.
Univ. Bordeaux, INSERM, UMR 1045, Cardiothoracic Research Center of Bordeaux, Pessac, France
5.
Department of Nuclear Medicine, John Paul II Hospital, Jagiellonian University Medical College, Krakow, Poland
6.
Department of Robotics and Mechatronics, AGH University of Science and Technology, Krakow, Poland
7.
Department of General and Vascular Surgery, Medical University of Silesia, Katowice, Poland
8.
Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland
9.
Department of Electrocardiology and Heart Failure, Medical University of Silesia, Katowice, Poland
10.
Interventional Cardiac Electrophysiology Group, International Clinical Research Center, St. Anne’s University Hospital, Brno, Czech Republic
11.
1st Department of Internal Medicine – Cardioangiology, St. Anne’s University Hospital, Brno, Czech Republic
Adv Interv Cardiol 2021; 17, 3 (65): 281–289
Online publish date: 2021/09/14
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
Cell therapy has the potential to improve symptoms and clinical outcomes in refractory angina (RFA). Further analyses are needed to evaluate factors influencing its therapeutic effectiveness. Aim: Assessment of electromechanical (EM) parameters of the left ventricle (LV) and investigation of correlation between EM parameters of the myocardium and response to CD133+ cell therapy.

Material and methods
Thirty patients with RFA (16 active and 14 placebo individuals) enrolled in the REGENT-VSEL trial underwent EM evaluation of the LV with intracardiac mapping system. The following parameters were analyzed: unipolar voltage (UV), bipolar voltage (BV), local linear shortening (LLS). Myocardial ischemia was evaluated with single-photon emission computed tomography (SPECT). The median value of each EM parameter was used for intra-group comparisons.

Results
Global EM parameters (UV, BV, LLS) of LV in active and placebo groups were 11.28 mV, 3.58 mV, 11.12%, respectively; 13.00 mV, 3.81 mV, 11.32%, respectively. EM characteristics analyzed at global and segmental levels did not predict response to CD133+ cell therapy in patients with RFA (Global UV, BV and LLS at rest R = –0.06; R = 0.2; R = –0.1 and at stress: R = 0.07, R = 0.09, R = –0.1, respectively; Segmental UV, BV, LLS at rest R = –0.2, R = 0.03, R = –0.4 and at stress R = 0.02, R = 0.2, R = –0.2, respectively). Multiple linear regression of the treated segments showed that only pre-injection SPECT levels were significantly correlated with post-injection SPECT, either at rest or stress (p < 0.05).

Conclusions
Electromechanical characteristics of the left ventricle do not predict changes of myocardial perfusion by SPECT after cell therapy. Baseline SPECT results are only predictors of changes of myocardial ischemia observed at 4-month follow-up.

keywords:

electromechanical mapping, refractory angina, CD133+, cell therapy, NOGA XP

Quick links
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.